insights_auto
Why is ALK-B down 2.37%?
Dive Deeperchevron_right
ALK-B:CPH
ALK-Abello A/S
DKKÂ 239.20
arrow_downward
-2.37%(-5.80) 1D
Nov 20, 5:00:00 PM GMT+1 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALK-B...
Open
DKKÂ 243.80
High
DKKÂ 244.00
Low
DKKÂ 238.60
Mkt. cap
49.63B
Avg. vol.
203.93K
Volume
185.88K
52-wk high
DKKÂ 271.40
52-wk low
DKKÂ 191.80
Shares outstanding
202.57M
No. of employees
3K
Open
DKKÂ 243.80
High
DKKÂ 244.00
Low
DKKÂ 238.60
Mkt. cap
49.63B
Avg. vol.
203.93K
Volume
185.88K
52-wk high
DKKÂ 271.40
52-wk low
DKKÂ 191.80
Shares outstanding
202.57M
No. of employees
3K
News stories
From web sources and news partners
The Arkansas Democrat-Gazette
·
33 minutes ago
AI-led sell-off drags S&P 500 down by 3.7%
Traders Union
·
3 hours ago
VIX fear index hits highest level since April 2025 as S&P 500 plunges
Trefis
·
1 hour ago
25 S&P 500 Stocks Just Made New 52-Week Lows
BigGo Finance
·
13 hours ago
Goldman Sachs: Year-End S&P 500 Rally Could Lose Half Its Punch as Fear Runs Hot
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter Halling
Employees2.8K
Founded1923
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealk.net